{"gene":"NELL1","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1999,"finding":"NELL1 and NELL2 proteins expressed in COS-7 cells are homotrimeric glycoproteins with heparin-binding activity, contain an N-terminal thrombospondin-1-like module, five von Willebrand factor C domains, and six EGF-like domains, and are partially secreted into culture medium while showing distinct subcellular cytoplasmic localization.","method":"Recombinant protein expression in COS-7 cells, biochemical characterization (heparin-binding assay, glycoprotein analysis)","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro biochemical reconstitution in COS-7 cells with functional characterization, single lab, single study","pmids":["10548494"],"is_preprint":false},{"year":1999,"finding":"NELL1 mRNA is specifically expressed in neural tissue and in mesenchymal cells/osteoblasts at osteogenic fronts of prematurely fusing cranial sutures, and is upregulated in unilateral coronal synostosis; its expression is largely absent in tibiae and fibroblast cultures but present in rat calvarial osteoprogenitor cells.","method":"In situ hybridization, Northern blot (multiorgan tissue mRNA blot), RT-PCR in rat calvarial cells","journal":"Journal of bone and mineral research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization experiment with tissue context, replicated across human and rat tissues in single study","pmids":["9893069"],"is_preprint":false},{"year":2002,"finding":"Overexpression of Nell-1 in transgenic mice is sufficient to induce craniosynostosis-like phenotypes, accelerate calvarial osteoblast differentiation and mineralization, and promote alkaline phosphatase expression and micronodule formation in vitro; conversely, Nell-1 downregulation inhibits osteoblast differentiation in vitro.","method":"Transgenic mouse overexpression model, in vitro calvarial osteoblast culture with Nell-1 overexpression/knockdown, histology, alkaline phosphatase assay","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function and gain-of-function with specific cellular phenotype, replicated in vivo and in vitro, multiple orthogonal methods","pmids":["12235118"],"is_preprint":false},{"year":2003,"finding":"Overexpression of Nell-1 induces apoptosis specifically in osteoblastic cells (not in NIH3T3 fibroblasts), associated with modulation of apoptosis-related genes; the craniosynostosis mouse model overexpressing Nell-1 showed increased apoptosis in calvaria.","method":"Viral transduction, recombinant protein treatment, apoptosis assays, gene expression analysis in osteoblastic cells and primary fibroblasts, in vivo mouse model","journal":"Journal of bone and mineral research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO/OE with defined cellular phenotype and cell-type specificity, multiple orthogonal methods in single lab","pmids":["14672347"],"is_preprint":false},{"year":2006,"finding":"Nell-1 deficiency (ENU-induced Cys502Ter truncation) in mice results in cranial and vertebral skeletal defects and is associated with reduced expression of extracellular matrix genes critical for chondrogenesis and osteogenesis, revealing a role for Nell1 in signal transduction in both intramembranous and endochondral ossification.","method":"ENU mutagenesis, positional cloning, real-time quantitative RT-PCR of 219 genes, skeletal phenotyping","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function mouse model with defined molecular and phenotypic readouts, multiple orthogonal methods","pmids":["16537572"],"is_preprint":false},{"year":2006,"finding":"Nell-1 overexpression during embryonic development induces acrania via massive apoptosis in calvarial osteoblasts and neural cells, associated with increased Fas and Fas-L production; transgenic mice also showed premature hypertrophy and increased apoptosis of chondrocytes.","method":"Transgenic mouse embryo analysis, apoptosis assays, immunostaining for Fas/Fas-L, in vitro primary chondrocyte AdNell-1 transduction","journal":"Laboratory investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic model with defined molecular mechanism (Fas/Fas-L), validated in vitro, single lab","pmids":["16652108"],"is_preprint":false},{"year":2007,"finding":"NELL1 protein transiently activates the MAPK signaling cascade, induces phosphorylation of Runx2, and promotes rapid intracellular accumulation of Tyr-phosphorylated proteins in osteoblastic cells; unlike BMP2, NELL1 does not activate the Smad signaling cascade.","method":"In vitro signaling assays (MAPK activation, phospho-protein analysis, Smad pathway assay) in osteoblastic cells treated with recombinant NELL1 protein","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro signaling assay with negative control (Smad), multiple pathway readouts, single lab","pmids":["18082140"],"is_preprint":false},{"year":2007,"finding":"Runx2 directly binds to three OSE2 elements in the NELL-1 promoter and transactivates NELL-1 expression; forced Runx2 expression induces NELL-1 in rat calvarial cells and rescues NELL-1 expression in Runx2-null calvarial cells.","method":"Promoter-luciferase reporter assays, gel shift/supershift with Runx2 antibodies, ChIP assay, site-directed mutagenesis, RT-PCR in Runx2 null cells","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 1 / Strong — promoter mutagenesis, EMSA, ChIP, and functional rescue in Runx2-null cells; multiple orthogonal methods","pmids":["17042739"],"is_preprint":false},{"year":2007,"finding":"Nell-1 and BMP-2 synergistically enhance osteogenic differentiation of C2C12 myoblasts and activate the JNK MAPK pathway; Nell-1 alone does not induce osteogenic differentiation of myoblasts, demonstrating osteochondral lineage specificity.","method":"Adenoviral transduction of C2C12 myoblasts, alkaline phosphatase activity, osteopontin production, MAPK signaling analysis (JNK, p38, ERK1/2), nude mouse muscle injection model","journal":"Journal of bone and mineral research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD/OE with specific cellular phenotype and pathway placement (JNK specificity), in vivo validation, single lab","pmids":["17352654"],"is_preprint":false},{"year":2011,"finding":"NELL-1 directly binds to extracellular Integrinβ1, induces focal adhesion, and promotes cell adherence; siRNA knockdown of Integrinβ1 abolishes NELL-1-mediated cell surface binding and enhanced cell attachment.","method":"Co-immunoprecipitation (NELL-1 binding to Integrinβ1), siRNA knockdown, cell adhesion assays in multiple cell lines, PLGA scaffold pre-coating experiments","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — receptor identification by Co-IP with siRNA validation and functional consequence (cell adhesion), single lab, multiple cell lines","pmids":["22807400"],"is_preprint":false},{"year":2011,"finding":"NELL-1 is a direct transcriptional target of Osterix, which suppresses NELL-1 expression by binding to Sp1 sites in the NELL-1 promoter; knockdown of Osterix increases NELL-1 transcription and osteoblastic differentiation.","method":"Promoter-luciferase reporter assays, site-directed mutagenesis (Sp1 sites), EMSA, ChIP assay in Saos-2 cells and primary human osteoblasts, siRNA knockdown of Osterix","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Strong — promoter mutagenesis, EMSA, ChIP, and siRNA knockdown with functional readout; multiple orthogonal methods in single rigorous study","pmids":["21931789"],"is_preprint":false},{"year":2011,"finding":"Nell-1 is a critical downstream mediator of Runx2: Nell-1 signaling activates ERK1/2 and JNK1 MAPK pathways and enhances Runx2 phosphorylation; genetic rescue experiments showed Nell-1 can partially rescue calvarial defects in Runx2 haploinsufficient mice, but requires at least one Runx2 allele for mineralization.","method":"CMV-Nell-1 × Runx2+/- cross-mating, siRNA knockdown of Nell-1, ENU-induced Nell-1-/- calvarial cells, MAPK pathway analysis, calvarial explant bone formation assays","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in multiple mouse models, MAPK signaling pathway placement, siRNA knockdown with defined phenotype; multiple orthogonal methods","pmids":["20939017"],"is_preprint":false},{"year":2011,"finding":"Nfatc2 is a primary response gene of Nell-1 in chondrocytes; Nell-1 transiently induces Nfatc2 transcription and translation through a Runx2-dependent mechanism, and siRNA knockdown of Nfatc2 reverses Nell-1's inhibitory effects on chondrocyte differentiation.","method":"Microarray screen, real-time PCR validation, dominant-negative Runx2 adenoviral transduction, siRNA knockdown of Nfatc2, ATDC5 and primary mouse chondrocyte assays, immunohistochemistry in wild-type and Nell1-deficient mouse femurs","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 2 / Strong — microarray with validation, dominant-negative epistasis, siRNA rescue, in vivo corroboration; multiple orthogonal methods in single study","pmids":["21611965"],"is_preprint":false},{"year":2011,"finding":"NELL-1 binds to APR3 (apoptosis related protein 3), a membrane proliferation suppressor; NELL-1 and APR3 co-localize on the nuclear envelope of human osteoblasts, and NELL-1 inhibits osteoblast proliferation via APR3 through down-regulation of Cyclin D1; RNAi of APR3 significantly reduces the differentiation effect of NELL-1.","method":"Biopanning for NELL-1 binding proteins, co-localization (immunofluorescence), co-transfection experiments, RNAi of APR3, osteogenic differentiation and proliferation assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — biopanning identification of binding partner, co-localization, and RNAi validation with functional readout; single lab but multiple methods","pmids":["21723284"],"is_preprint":false},{"year":2012,"finding":"The C-terminal region of NELL1 mediates osteoblastic cell adhesion through integrin α3β1; function-blocking antibodies against integrin α3 and β1 subunits strongly inhibit cell adhesion to NELL1, and focal adhesion kinase (FAK) activation is involved in NELL1 signaling.","method":"Series of recombinant NELL1 deletion and domain-mapping proteins, function-blocking antibody experiments, FAK activation assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — systematic domain deletion mutagenesis, blocking antibody inhibition, FAK signaling readout; single lab","pmids":["22728432"],"is_preprint":false},{"year":2014,"finding":"NELL1-mediated cell adhesion and spreading requires oligomerization: a cysteine-to-serine mutant NELL1 that cannot form homo-oligomers shows substantially lower cell adhesion activity; an oligomerization-induced conformational change in the C-terminal cysteine-rich region is critical for NELL1 adhesive function.","method":"Recombinant NELL1 proteins (intact, deleted, cysteine-mutant), reducing agent treatment, site-directed cysteine-to-serine mutagenesis at coiled-coil domain, cell adhesion assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic structure-function mutagenesis with reconstituted proteins, multiple deletion and point mutants tested, mechanistic conformational change identified","pmids":["24563467"],"is_preprint":false},{"year":2015,"finding":"NELL1 binds to cell surface proteoglycans through its N-terminal thrombospondin-1-like (TSPN) domain; mutational analysis of predicted heparin-binding sites on a 3D structural model of the TSPN domain confirmed that heparin-binding activity of this domain mediates interaction with cell surface proteoglycans.","method":"Site-directed mutagenesis of TSPN domain heparin-binding sites, 3D structural modeling, cell surface proteoglycan binding assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — site-directed mutagenesis with functional binding assay, structural model guidance; single lab","pmids":["26627376"],"is_preprint":false},{"year":2015,"finding":"Recombinant NELL-1 binds to integrin β1 and induces Wnt/β-catenin signaling, which is associated with increased osteoblast differentiation and inhibition of osteoclast-directed bone resorption; Nell-1-haploinsufficient mice develop age-related osteoporosis with a reduced osteoblast:osteoclast ratio.","method":"Recombinant protein binding assay (integrin β1), Wnt/β-catenin signaling analysis, Nell-1 haploinsufficient mouse model, systemic NELL-1 delivery in gonadectomy-induced osteoporotic mice and sheep","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — receptor binding with downstream pathway (Wnt/β-catenin), loss-of-function mouse model with specific phenotype, confirmed in large animal model; multiple orthogonal methods","pmids":["26082355"],"is_preprint":false},{"year":2012,"finding":"NELL-1 increases pre-osteoblast mineralization through activation of both phosphate transporter Pit1 and Pit2; neutralizing antibodies against Pit-1 and Pit-2 completely abrogate NELL-1-induced Pi influx, distinguishing NELL-1 from BMP-2 which uses only Pit-1.","method":"Recombinant NELL-1 and BMP-2 treatment of MC3T3-E1 pre-osteoblasts, intracellular Pi quantification (malachite green), Pit-1/Pit-2 expression analysis, neutralizing antibodies","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — neutralizing antibody functional blockade identifies specific transporters, mechanistic distinction from BMP-2 established; single lab","pmids":["22580275"],"is_preprint":false},{"year":2013,"finding":"NELL-1 suppresses BMP2-induced NF-κB transcriptional activity and generation of reactive oxygen species (ROS) in fibroblasts, attenuating BMP2-induced inflammation (TNFα, IL6) both locally and systemically in rats.","method":"In vivo rat femoral bone onlay with histology, immunohistochemistry, real-time PCR, ELISA for TNFα/IL6; in vitro NIH3T3 cell assays for NF-κB activity and ROS","journal":"Tissue engineering. Part A","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro validation with specific molecular mechanism (NF-κB, ROS), multiple readouts; single lab","pmids":["23758588"],"is_preprint":false},{"year":2017,"finding":"NELL-1 induces Sca-1 transcription in mesenchymal progenitor cells (MPCs) in a process requiring intact Wnt/β-catenin signaling; Nell-1 haploinsufficiency reduces Sca-1+CD45-CD31- bone marrow MPCs, while systemic rhNELL-1 administration increases this population.","method":"Nell-1 haploinsufficient mouse analysis (flow cytometry), systemic rhNELL-1 administration, Wnt/β-catenin pathway inhibition, nonhuman primate spinal fusion model","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function and pharmacological gain-of-function with pathway inhibition (Wnt/β-catenin required), multiple animal models; single lab","pmids":["28614787"],"is_preprint":false},{"year":2018,"finding":"Chondrocyte-specific inactivation of Nell-1 (Col2α1-Cre) impedes appendicular skeletogenesis and osteoporosis through inhibition of Ihh signaling and alteration of the Ihh-PTHrP feedback loop; exogenous Nell-1 protein partially rescues decreased proliferation/differentiation of Nell-1-deficient chondrocytes, and this rescue is diminished by Ihh signaling inhibitors (cyclopamine or GANT61).","method":"Conditional knockout mice (Nell-1flox/flox; Col2α1-Cre+), micro-CT, histomorphometry, immunohistochemistry (Ihh, Patched-1, PTHrP, PTHrP receptor, Gli-1), Ihh inhibitor rescue experiments","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific knockout with defined signaling pathway (Ihh-PTHrP), pharmacological pathway inhibition confirmation, multiple orthogonal methods","pmids":["30352124"],"is_preprint":false},{"year":2019,"finding":"Neural crest cell (Wnt1 lineage)-specific Nell-1 inactivation causes frontonasal and mandibular bone defects with decreased Wnt/β-catenin markers; Nell-1-deficient cranial neural crest cells (CNCCs) show reduced proliferation and osteogenic differentiation, and exogenous Nell-1 rescues active-β-catenin levels and osteogenic capacity.","method":"Nell-1flox/flox; Wnt1-Cre conditional knockout mice, lineage tracing, immunostaining (Osteocalcin, active-β-catenin), primary CNCC culture with Nell-1 protein rescue","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with lineage tracing, protein rescue experiment, Wnt/β-catenin pathway linkage; multiple orthogonal methods","pmids":["31582804"],"is_preprint":false},{"year":2019,"finding":"A specific receptor for NELL-1 in osteogenesis was identified as contactin-associated protein-like 4 (Cntnap4); NELL-1 signaling involves MAPK and Wnt/β-catenin pathways with key regulatory roles for Runx2.","method":"Cited in review as identified receptor (Cntnap4 for osteogenesis); supporting MAPK and Wnt/β-catenin pathway data from referenced primary studies","journal":"Journal of dental research","confidence":"Low","confidence_rationale":"Tier 4 / Weak — receptor identification (Cntnap4) cited in a review without primary experimental detail in this abstract; cannot confirm tier from available text","pmids":["31610747"],"is_preprint":false},{"year":2012,"finding":"NELL-1 inhibits adipogenic differentiation and increases expression of Hedgehog signaling markers (Ihh, Gli1, Ptc1); co-application of the Smoothened antagonist Cyclopamine reverses the pro-osteogenic effect of NELL-1, indicating NELL-1's anti-adipogenic effect is partly Hedgehog-dependent.","method":"Adenoviral NELL-1 delivery and recombinant NELL-1 protein in 3T3-L1 and human adipose-derived stromal cells, hedgehog pathway inhibitor (Cyclopamine) blockade, oil red O staining, gene expression","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway inhibition (Cyclopamine reversal) with gene expression readout; single lab, two orthogonal methods","pmids":["21723263"],"is_preprint":false},{"year":2018,"finding":"Nell-1 enhances osteogenic differentiation of pre-osteoblasts on titanium surfaces via activation of MAPK/ERK (and JNK) signaling; ERK inhibitor U0126 suppresses the promotive effect of Nell-1 on most osteogenic markers.","method":"Recombinant Nell-1 treatment of MC3T3-E1 on Ti surfaces, Western blot for MAPK pathway, ERK inhibitor U0126 blockade, ALP assay, ELISA, RT-PCR","journal":"Cellular physiology and biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibitor (U0126) reversal identifies ERK pathway requirement; single lab, multiple readouts","pmids":["30359975"],"is_preprint":false},{"year":2018,"finding":"A novel NELL-1 transcript (Nell-1-ΔE) lacking one EGF-like domain, but not full-length Nell-1, inhibits cell migration by interacting with enolase-1 (ENO-1) in the extracellular space; this interaction was confirmed by co-immunoprecipitation and LC/MS-MS.","method":"Homology modeling, recombinant protein production, Co-IP/LC-MS-MS identification of ENO-1 as Nell-1-ΔE binding partner, wound healing assay in ENO-1-overexpressing cells","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP/MS identification of binding partner with functional wound-healing assay validation; single lab","pmids":["29388706"],"is_preprint":false},{"year":2022,"finding":"Genetic deletion of NELL1 in osteosarcoma cell lines reduces invasive behavior and FAK signaling; transcriptomic and phosphoproteomic analyses show NELL1 loss skews matricellular protein expression; culturing NELL1-knockout sarcoma cells on wild-type OS-enriched matricellular proteins reverses the phenotypic and signaling changes.","method":"NELL1 genetic deletion in human OS cell lines, xenograft mouse model, conditional Nell1 knockout in p53/Rb-driven sarcomagenesis mouse model, transcriptomics, phosphoproteomics, ECM rescue experiment","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with defined FAK signaling mechanism, ECM rescue experiment, validated in human and mouse models; multiple orthogonal methods","pmids":["35700263"],"is_preprint":false},{"year":2024,"finding":"Nell-1 promotes macrophage polarization from M1 to M2 phenotype through the JNK/MAPK signaling pathway; JNK inhibitor SP600125 reverses Nell-1's effect on macrophage polarization in LPS-stimulated RAW 264.7 cells.","method":"LPS-stimulated RAW 264.7 macrophages treated with Nell-1 protein, JNK inhibitor SP600125 blockade, RT-PCR, Western blot, flow cytometry for M1/M2 markers; rat ligation-induced periodontitis model","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibitor reversal (JNK inhibitor) identifies specific pathway, in vivo and in vitro validation; single lab","pmids":["38908089"],"is_preprint":false},{"year":2019,"finding":"NELL1 reduces colony formation, invasion, and chemotherapeutic resistance of lung cancer stem-like cells, associated with reduced phospho-MET, Notch3, and HES1 expression, suggesting NELL1 induces differentiation by inhibiting c-MET-Notch signaling.","method":"NELL1 overexpression in 95-D lung cancer stem-like cells, soft agar colony formation, invasion assay, cell proliferation assay with carboplatin/cisplatin, Western blot for p-MET/Notch3/HES1","journal":"Oncology reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single gene overexpression with pathway marker readout but no inhibitor/rescue validation; single lab, single method per endpoint","pmids":["30628703"],"is_preprint":false},{"year":2019,"finding":"NELL1 is expressed in glomeruli and detected as a target antigen in membranous nephropathy; IgG co-localizes with NELL1 along the glomerular basement membrane, and patients have serum anti-NELL1 antibodies reactive by Western blot.","method":"Laser microdissection/mass spectrometry of glomeruli, immunohistochemistry, confocal microscopy co-localization, Western blot with patient sera","journal":"Kidney international","confidence":"High","confidence_rationale":"Tier 2 / Strong — antigen discovery by mass spectrometry validated by IHC, co-localization, and serology across multiple patient cohorts; replicated in validation cohorts","pmids":["31901340"],"is_preprint":false}],"current_model":"NELL1 is a secreted homotrimeric glycoprotein that functions as an osteoinductive growth factor downstream of the Runx2/Osterix transcriptional axis; it signals through integrin β1 (and integrin α3β1) to activate MAPK (ERK1/2, JNK1) pathways, promote Wnt/β-catenin signaling, and phosphorylate Runx2, thereby driving osteoblast differentiation and inhibiting adipogenesis, osteoclastogenesis, and inflammation; in chondrocytes it regulates the Ihh-PTHrP feedback loop via Nfatc2; it binds heparin/proteoglycans through its TSPN domain and requires oligomerization for efficient cell adhesion; additionally, it functions as an autoantigen in a subset of membranous nephropathy where circulating anti-NELL1 IgG1 antibodies drive glomerular immune-complex deposition, and in osteosarcoma it modulates the ECM matrisome to promote FAK-dependent invasion."},"narrative":{"mechanistic_narrative":"NELL1 is a secreted homotrimeric, heparin-binding glycoprotein that acts as an osteoinductive signaling molecule controlling skeletal cell fate during both intramembranous and endochondral ossification [PMID:10548494, PMID:16537572]. Its expression is restricted to neural tissue and osteogenic fronts, where it is concentrated in mesenchymal/osteoblast lineages at cranial sutures [PMID:9893069]. NELL1 sits downstream of the master osteoblast transcription factor axis: Runx2 directly binds OSE2 elements in the NELL1 promoter to activate transcription, while Osterix represses it through Sp1 sites, placing NELL1 under bidirectional transcriptional control [PMID:17042739, PMID:21931789]. Gain- and loss-of-function mouse models establish that NELL1 dosage is sufficient and required for normal skeletogenesis, with overexpression driving craniosynostosis-like phenotypes and accelerated osteoblast differentiation and deficiency producing cranial and vertebral defects [PMID:12235118, PMID:16537572]. Functionally, NELL1 engages cell-surface receptors—integrin β1 and integrin α3β1—to nucleate focal adhesions and activate FAK, and signals through MAPK (ERK1/2, JNK1) cascades that feed back to phosphorylate Runx2, while sparing the Smad pathway used by BMP2 [PMID:22807400, PMID:20939017, PMID:22728432, PMID:18082140]. Downstream of receptor engagement, NELL1 promotes Wnt/β-catenin signaling to expand osteogenic progenitors and tip the osteoblast:osteoclast balance toward bone formation, with haploinsufficient mice developing age-related osteoporosis [PMID:26082355, PMID:28614787]. NELL1 also acts as a checkpoint between lineages: it inhibits adipogenesis through Hedgehog signaling and, in chondrocytes, induces Nfatc2 in a Runx2-dependent manner and modulates the Ihh–PTHrP feedback loop to govern chondrocyte proliferation and differentiation [PMID:21723263, PMID:21611965, PMID:30352124]. Adhesive activity requires cysteine-dependent oligomerization, and proteoglycan binding is mediated by heparin-binding sites in the N-terminal TSPN domain [PMID:24563467, PMID:26627376]. Beyond skeletal biology, NELL1 is a glomerular target autoantigen in membranous nephropathy, where patient IgG co-localizes with NELL1 along the glomerular basement membrane [PMID:31901340], and in osteosarcoma NELL1 shapes the matricellular environment to sustain FAK-dependent invasion [PMID:35700263].","teleology":[{"year":1999,"claim":"Established NELL1's molecular nature—answering what kind of protein it is—by showing it is a secreted, homotrimeric, heparin-binding glycoprotein built from TSPN, von Willebrand C, and EGF-like modules expressed selectively in neural and cranial osteogenic tissue.","evidence":"Recombinant expression in COS-7 cells with biochemical characterization, plus in situ hybridization/Northern/RT-PCR across human and rat tissues","pmids":["10548494","9893069"],"confidence":"Medium","gaps":["No receptor or signaling pathway identified at this stage","Functional consequence of secretion not tested"]},{"year":2002,"claim":"Demonstrated NELL1 is a functional regulator of osteoblast differentiation in vivo, resolving whether its restricted expression was causal—transgenic overexpression drives craniosynostosis and accelerated mineralization while knockdown blocks differentiation.","evidence":"Transgenic mouse overexpression and in vitro calvarial osteoblast culture with overexpression/knockdown, histology and ALP assays","pmids":["12235118"],"confidence":"High","gaps":["Signaling mechanism and receptor unknown","Did not distinguish direct osteoinduction from apoptosis-mediated remodeling"]},{"year":2006,"claim":"Defined NELL1's requirement and apoptotic activity in skeletal patterning—loss-of-function causes cranial/vertebral defects with reduced ECM gene expression, while excess NELL1 triggers Fas/Fas-L-dependent apoptosis of osteoblasts and chondrocytes.","evidence":"ENU-induced truncation mouse, positional cloning, qRT-PCR of 219 genes, transgenic embryo apoptosis analysis with Fas/Fas-L immunostaining","pmids":["16537572","16652108","14672347"],"confidence":"High","gaps":["Direct molecular target driving ECM gene changes not identified","Apoptotic mechanism cell-type specificity not fully explained"]},{"year":2007,"claim":"Placed NELL1 within the osteoblast transcriptional hierarchy and its proximal signaling output—Runx2 directly transactivates NELL1, and NELL1 in turn activates MAPK and phosphorylates Runx2 without engaging Smad, distinguishing it from BMP2.","evidence":"Promoter-luciferase, EMSA, ChIP, rescue in Runx2-null cells; in vitro MAPK and Smad signaling assays with recombinant NELL1; C2C12 synergy with BMP2","pmids":["17042739","18082140","17352654"],"confidence":"High","gaps":["Cell-surface receptor mediating MAPK activation not yet identified","Mechanism of Runx2 phosphorylation feedback unresolved"]},{"year":2011,"claim":"Identified NELL1 cell-surface receptors and downstream effectors, answering how the secreted protein transduces signal—it binds integrin β1, activates ERK1/2 and JNK1 to phosphorylate Runx2, is repressed by Osterix, and induces chondrocyte Nfatc2 in a Runx2-dependent manner.","evidence":"Co-IP and siRNA for integrin β1; genetic epistasis in Runx2+/- and Nell1-/- mice; Osterix promoter ChIP/EMSA/siRNA; microarray with Nfatc2 siRNA rescue and APR3 biopanning","pmids":["22807400","20939017","21931789","21611965","21723284"],"confidence":"High","gaps":["Whether integrin β1 is the sole or primary receptor unresolved","Structural basis of receptor engagement unknown"]},{"year":2012,"claim":"Resolved the adhesion receptor and lineage-balancing functions—NELL1's C-terminus mediates adhesion through integrin α3β1 with FAK activation, it activates phosphate transporters Pit1/Pit2 distinct from BMP2, and inhibits adipogenesis via Hedgehog signaling.","evidence":"Domain-mapping deletion proteins and α3/β1 blocking antibodies with FAK assay; Pi influx with Pit-1/Pit-2 neutralizing antibodies; Cyclopamine reversal in adipose-derived stromal cells","pmids":["22728432","22580275","21723263"],"confidence":"Medium","gaps":["Relationship between integrin α3β1 and β1 receptor reports not reconciled","Direct Hedgehog ligand interaction not tested"]},{"year":2014,"claim":"Defined the structural requirement for NELL1 adhesion—cysteine-dependent oligomerization producing a conformational change in the C-terminal cysteine-rich region is essential, and TSPN heparin-binding sites mediate proteoglycan engagement.","evidence":"Systematic deletion/cysteine-to-serine mutagenesis with reducing-agent and adhesion assays; TSPN domain heparin-binding site mutagenesis guided by 3D modeling","pmids":["24563467","26627376"],"confidence":"High","gaps":["No experimental atomic structure of full-length oligomer","How oligomerization couples to receptor activation not shown"]},{"year":2015,"claim":"Linked NELL1 receptor binding to Wnt/β-catenin output and systemic bone homeostasis—integrin β1 binding induces Wnt/β-catenin signaling that favors osteoblasts over osteoclasts, with haploinsufficiency causing osteoporosis.","evidence":"Recombinant integrin β1 binding and Wnt/β-catenin analysis, Nell1 haploinsufficient mouse, systemic delivery in osteoporotic mice and sheep","pmids":["26082355"],"confidence":"High","gaps":["Mechanistic link from integrin engagement to Wnt activation not detailed","Receptor for Wnt induction versus adhesion not separated"]},{"year":2017,"claim":"Connected NELL1 to progenitor pool expansion—NELL1 induces Sca-1 in mesenchymal progenitors through Wnt/β-catenin, and dosage controls the marrow MPC population.","evidence":"Haploinsufficient mouse flow cytometry, systemic rhNELL-1, Wnt/β-catenin inhibition, nonhuman primate spinal fusion","pmids":["28614787"],"confidence":"Medium","gaps":["Direct transcriptional mechanism of Sca-1 induction unknown","Receptor mediating progenitor effect not identified"]},{"year":2018,"claim":"Established the chondrocyte-autonomous role of NELL1 in endochondral ossification—conditional deletion in cartilage impairs skeletogenesis via the Ihh–PTHrP feedback loop, with rescue blocked by Ihh inhibitors; NELL1 also signals through MAPK/ERK on osteogenic surfaces.","evidence":"Col2α1-Cre conditional knockout with micro-CT/histomorphometry and Ihh/PTHrP immunostaining, Ihh inhibitor rescue; ERK inhibitor U0126 blockade on Ti surfaces; Nell-1-ΔE/ENO-1 Co-IP/MS","pmids":["30352124","30359975","29388706"],"confidence":"High","gaps":["How NELL1 engages the Ihh pathway molecularly unresolved","Function of the ΔE splice variant/ENO-1 axis in vivo unknown"]},{"year":2019,"claim":"Extended NELL1 to neural crest skeletogenesis, a candidate osteogenic receptor, autoimmune kidney disease, and tumor suppression—Wnt1-lineage deletion causes craniofacial defects via reduced β-catenin, Cntnap4 was named as an osteogenic receptor, NELL1 is a membranous nephropathy autoantigen, and it restrains lung cancer stem-like cells.","evidence":"Wnt1-Cre conditional knockout with lineage tracing and protein rescue; review citation of Cntnap4; glomerular mass spectrometry/IHC/serology; NELL1 overexpression in lung cancer stem-like cells with pathway markers","pmids":["31582804","31610747","31901340","30628703"],"confidence":"High","gaps":["Cntnap4 receptor claim is review-level, lacking primary detail (Low confidence)","Lung cancer c-MET-Notch link lacks inhibitor/rescue validation (Low confidence)","Mechanism converting NELL1 from skeletal factor to glomerular autoantigen unknown"]},{"year":2022,"claim":"Revealed a context-dependent oncogenic role—in osteosarcoma NELL1 sustains invasion and FAK signaling by shaping the matricellular environment, with ECM rescue restoring the phenotype.","evidence":"Genetic deletion in human OS lines, xenograft and p53/Rb-driven sarcoma conditional knockout, transcriptomics/phosphoproteomics, matricellular ECM rescue","pmids":["35700263"],"confidence":"High","gaps":["Receptor mediating OS FAK signaling not specified","Reconciliation of tumor-suppressive versus pro-invasive roles across cancers unresolved"]},{"year":2024,"claim":"Identified an immunomodulatory function—NELL1 drives macrophage M1-to-M2 polarization through JNK/MAPK signaling, linking it to resolution of inflammation in bone-associated tissue.","evidence":"LPS-stimulated RAW 264.7 macrophages with JNK inhibitor SP600125 blockade, flow cytometry, plus rat periodontitis model","pmids":["38908089"],"confidence":"Medium","gaps":["Receptor on macrophages not identified","Single cell-line context for the polarization mechanism"]},{"year":null,"claim":"The unifying receptor logic remains open: how NELL1 reconciles integrin β1, integrin α3β1, and the proposed Cntnap4 into a coherent receptor system, and how the same molecule acts as osteoinductive factor, lineage gatekeeper, autoantigen, and context-dependent tumor modulator.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of receptor-bound NELL1","No single study reconciles divergent receptor identifications","Mechanism of autoantigen exposure in membranous nephropathy uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[2,6,11,17]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,16]},{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[9,14,15]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[9,14,17]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,17,30]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[27]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,11,17,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,4,21,22]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[4,27]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[7,10]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[28,30]}],"complexes":[],"partners":["ITGB1","ITGA3","RUNX2","SP7","CNTNAP4","APR3","ENO1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q92832","full_name":"Protein kinase C-binding protein NELL1","aliases":["NEL-like protein 1","Nel-related protein 1"],"length_aa":810,"mass_kda":89.6,"function":"Plays a role in the control of cell growth and differentiation. Promotes osteoblast cell differentiation and terminal mineralization","subcellular_location":"Cytoplasm; Nucleus envelope; Secreted","url":"https://www.uniprot.org/uniprotkb/Q92832/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NELL1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NELL1","total_profiled":1310},"omim":[{"mim_id":"619682","title":"ALL-TRANS RETINOIC ACID-INDUCED DIFFERENTIATION FACTOR; ATRAID","url":"https://www.omim.org/entry/619682"},{"mim_id":"612262","title":"INFLAMMATORY BOWEL DISEASE 18; IBD18","url":"https://www.omim.org/entry/612262"},{"mim_id":"608663","title":"ANOCTAMIN 6; ANO6","url":"https://www.omim.org/entry/608663"},{"mim_id":"608662","title":"ANOCTAMIN 5; ANO5","url":"https://www.omim.org/entry/608662"},{"mim_id":"602320","title":"NEURAL EPIDERMAL GROWTH FACTOR-LIKE PROTEIN 2; NELL2","url":"https://www.omim.org/entry/602320"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":12.8},{"tissue":"kidney","ntpm":15.5}],"url":"https://www.proteinatlas.org/search/NELL1"},"hgnc":{"alias_symbol":["IDH3GL","FLJ45906"],"prev_symbol":[]},"alphafold":{"accession":"Q92832","domains":[{"cath_id":"2.60.120.200","chopping":"30-221","consensus_level":"high","plddt":86.1762,"start":30,"end":221},{"cath_id":"-","chopping":"319-364","consensus_level":"medium","plddt":77.0657,"start":319,"end":364},{"cath_id":"-","chopping":"376-435","consensus_level":"medium","plddt":77.025,"start":376,"end":435},{"cath_id":"2.10.70.10","chopping":"685-728","consensus_level":"medium","plddt":76.2289,"start":685,"end":728},{"cath_id":"-","chopping":"739-810","consensus_level":"medium","plddt":81.2446,"start":739,"end":810}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92832","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92832-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92832-F1-predicted_aligned_error_v6.png","plddt_mean":79.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NELL1","jax_strain_url":"https://www.jax.org/strain/search?query=NELL1"},"sequence":{"accession":"Q92832","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92832.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92832/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92832"}},"corpus_meta":[{"pmid":"31901340","id":"PMC_31901340","title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.","date":"2019","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/31901340","citation_count":275,"is_preprint":false},{"pmid":"32828756","id":"PMC_32828756","title":"NELL1 is a target antigen in malignancy-associated membranous nephropathy.","date":"2020","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/32828756","citation_count":146,"is_preprint":false},{"pmid":"9893069","id":"PMC_9893069","title":"Human NELL-1 expressed in unilateral coronal synostosis.","date":"1999","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/9893069","citation_count":145,"is_preprint":false},{"pmid":"12235118","id":"PMC_12235118","title":"Craniosynostosis in transgenic mice overexpressing Nell-1.","date":"2002","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12235118","citation_count":130,"is_preprint":false},{"pmid":"10548494","id":"PMC_10548494","title":"Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10548494","citation_count":119,"is_preprint":false},{"pmid":"8975702","id":"PMC_8975702","title":"Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8975702","citation_count":117,"is_preprint":false},{"pmid":"17684544","id":"PMC_17684544","title":"Systematic association mapping identifies NELL1 as a novel IBD disease gene.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17684544","citation_count":106,"is_preprint":false},{"pmid":"20647499","id":"PMC_20647499","title":"The role of NELL-1, a growth factor associated with craniosynostosis, in promoting bone regeneration.","date":"2010","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/20647499","citation_count":105,"is_preprint":false},{"pmid":"26082355","id":"PMC_26082355","title":"NELL-1 in the treatment of osteoporotic bone loss.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26082355","citation_count":99,"is_preprint":false},{"pmid":"16537572","id":"PMC_16537572","title":"Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16537572","citation_count":97,"is_preprint":false},{"pmid":"17197333","id":"PMC_17197333","title":"The osteoinductive properties of Nell-1 in a rat spinal fusion model.","date":"2006","source":"The spine journal : official journal of the North American Spine Society","url":"https://pubmed.ncbi.nlm.nih.gov/17197333","citation_count":87,"is_preprint":false},{"pmid":"20939017","id":"PMC_20939017","title":"Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) mice.","date":"2011","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/20939017","citation_count":79,"is_preprint":false},{"pmid":"22264144","id":"PMC_22264144","title":"Additive effects of sonic hedgehog and Nell-1 signaling in osteogenic versus adipogenic differentiation of human adipose-derived stromal cells.","date":"2012","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/22264144","citation_count":77,"is_preprint":false},{"pmid":"17653100","id":"PMC_17653100","title":"A study of the role of nell-1 gene modified goat bone marrow stromal cells in promoting new bone formation.","date":"2007","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/17653100","citation_count":76,"is_preprint":false},{"pmid":"23758588","id":"PMC_23758588","title":"BMP2-induced inflammation can be suppressed by the osteoinductive growth factor NELL-1.","date":"2013","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/23758588","citation_count":68,"is_preprint":false},{"pmid":"18082140","id":"PMC_18082140","title":"Involvement of MAPK signaling molecules and Runx2 in the NELL1-induced osteoblastic differentiation.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/18082140","citation_count":67,"is_preprint":false},{"pmid":"17352654","id":"PMC_17352654","title":"Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.","date":"2007","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/17352654","citation_count":67,"is_preprint":false},{"pmid":"21128865","id":"PMC_21128865","title":"Nell-1 protein promotes bone formation in a sheep spinal fusion model.","date":"2011","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/21128865","citation_count":64,"is_preprint":false},{"pmid":"17042739","id":"PMC_17042739","title":"Craniosynostosis-associated gene nell-1 is regulated by runx2.","date":"2007","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/17042739","citation_count":62,"is_preprint":false},{"pmid":"21285762","id":"PMC_21285762","title":"Nell-1 enhances bone regeneration in a rat critical-sized femoral segmental defect model.","date":"2011","source":"Plastic and reconstructive surgery","url":"https://pubmed.ncbi.nlm.nih.gov/21285762","citation_count":55,"is_preprint":false},{"pmid":"21615216","id":"PMC_21615216","title":"The Nell-1 growth factor stimulates bone formation by purified human perivascular cells.","date":"2011","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/21615216","citation_count":54,"is_preprint":false},{"pmid":"21723263","id":"PMC_21723263","title":"A new function of Nell-1 protein in repressing adipogenic differentiation.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21723263","citation_count":53,"is_preprint":false},{"pmid":"20528102","id":"PMC_20528102","title":"Delivery of lyophilized Nell-1 in a rat spinal fusion model.","date":"2010","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/20528102","citation_count":52,"is_preprint":false},{"pmid":"14672347","id":"PMC_14672347","title":"Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development.","date":"2003","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/14672347","citation_count":48,"is_preprint":false},{"pmid":"28214873","id":"PMC_28214873","title":"NEL-Like Molecule-1 (Nell1) Is Regulated by Bone Morphogenetic Protein 9 (BMP9) and Potentiates BMP9-Induced Osteogenic Differentiation at the Expense of Adipogenesis in Mesenchymal Stem Cells.","date":"2017","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28214873","citation_count":47,"is_preprint":false},{"pmid":"21902605","id":"PMC_21902605","title":"NELL-1 promotes cartilage regeneration in an in vivo rabbit model.","date":"2011","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/21902605","citation_count":42,"is_preprint":false},{"pmid":"22807400","id":"PMC_22807400","title":"NELL-1 promotes cell adhesion and differentiation via Integrinβ1.","date":"2012","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22807400","citation_count":40,"is_preprint":false},{"pmid":"36175952","id":"PMC_36175952","title":"Runx2 and Nell-1 in dental follicle progenitor cells regulate bone remodeling and tooth eruption.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/36175952","citation_count":39,"is_preprint":false},{"pmid":"20028218","id":"PMC_20028218","title":"Effect of Nell-1 delivery on chondrocyte proliferation and cartilaginous extracellular matrix deposition.","date":"2010","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/20028218","citation_count":39,"is_preprint":false},{"pmid":"20116699","id":"PMC_20116699","title":"The effect of NELL1 and bone morphogenetic protein-2 on calvarial bone regeneration.","date":"2010","source":"Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/20116699","citation_count":38,"is_preprint":false},{"pmid":"22580275","id":"PMC_22580275","title":"NELL-1 increases pre-osteoblast mineralization using both phosphate transporter Pit1 and Pit2.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22580275","citation_count":38,"is_preprint":false},{"pmid":"25726761","id":"PMC_25726761","title":"Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma.","date":"2015","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/25726761","citation_count":36,"is_preprint":false},{"pmid":"31610747","id":"PMC_31610747","title":"Nell-1 Is a Key Functional Modulator in Osteochondrogenesis and Beyond.","date":"2019","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/31610747","citation_count":36,"is_preprint":false},{"pmid":"36865014","id":"PMC_36865014","title":"The Many Faces of NELL1 MN.","date":"2022","source":"Clinical kidney journal","url":"https://pubmed.ncbi.nlm.nih.gov/36865014","citation_count":35,"is_preprint":false},{"pmid":"21723284","id":"PMC_21723284","title":"NELL-1 binds to APR3 affecting human osteoblast proliferation and differentiation.","date":"2011","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21723284","citation_count":34,"is_preprint":false},{"pmid":"21611965","id":"PMC_21611965","title":"Nfatc2 is a primary response gene of Nell-1 regulating chondrogenesis in ATDC5 cells.","date":"2011","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/21611965","citation_count":33,"is_preprint":false},{"pmid":"20959151","id":"PMC_20959151","title":"NELL1 promotes high-quality bone regeneration in rat femoral distraction osteogenesis model.","date":"2010","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/20959151","citation_count":31,"is_preprint":false},{"pmid":"23686083","id":"PMC_23686083","title":"NELL-1 based demineralized bone graft promotes rat spine fusion as compared to commercially available BMP-2 product.","date":"2013","source":"Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association","url":"https://pubmed.ncbi.nlm.nih.gov/23686083","citation_count":31,"is_preprint":false},{"pmid":"21703614","id":"PMC_21703614","title":"Combined effects of recombinant human BMP-2 and Nell-1 on bone regeneration in rapid distraction osteogenesis of rabbit tibia.","date":"2011","source":"Injury","url":"https://pubmed.ncbi.nlm.nih.gov/21703614","citation_count":30,"is_preprint":false},{"pmid":"10231576","id":"PMC_10231576","title":"The neuronal EGF-related genes NELL1 and NELL2 are expressed in hemopoietic cells and developmentally regulated in the B lineage.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10231576","citation_count":28,"is_preprint":false},{"pmid":"29276737","id":"PMC_29276737","title":"Neural EGF-like protein 1 (NELL-1): Signaling crosstalk in mesenchymal stem cells and applications in regenerative medicine.","date":"2017","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/29276737","citation_count":28,"is_preprint":false},{"pmid":"26700847","id":"PMC_26700847","title":"Accelerated Chondrogenic Differentiation of Human Perivascular Stem Cells with NELL-1.","date":"2016","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26700847","citation_count":27,"is_preprint":false},{"pmid":"21584647","id":"PMC_21584647","title":"Maxillary sinus floor elevation using BMP-2 and Nell-1 gene-modified bone marrow stromal cells and TCP in rabbits.","date":"2011","source":"Calcified tissue international","url":"https://pubmed.ncbi.nlm.nih.gov/21584647","citation_count":27,"is_preprint":false},{"pmid":"16652108","id":"PMC_16652108","title":"Nell-1 induces acrania-like cranioskeletal deformities during mouse embryonic development.","date":"2006","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16652108","citation_count":27,"is_preprint":false},{"pmid":"28463604","id":"PMC_28463604","title":"NELL-1, HMGB1, and CCN2 Enhance Migration and Vasculogenesis, But Not Osteogenic Differentiation Compared to BMP2.","date":"2017","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/28463604","citation_count":26,"is_preprint":false},{"pmid":"30359975","id":"PMC_30359975","title":"Nell-1 Enhances Osteogenic Differentiation of Pre-Osteoblasts on Titanium Surfaces via the MAPK-ERK Signaling Pathway.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30359975","citation_count":26,"is_preprint":false},{"pmid":"22337375","id":"PMC_22337375","title":"Calvarial cleidocraniodysplasia-like defects with ENU-induced Nell-1 deficiency.","date":"2012","source":"The Journal of craniofacial surgery","url":"https://pubmed.ncbi.nlm.nih.gov/22337375","citation_count":26,"is_preprint":false},{"pmid":"11803583","id":"PMC_11803583","title":"Brain specific human genes, NELL1 and NELL2, are predominantly expressed in neuroblastoma and other embryonal neuroepithelial tumors.","date":"2001","source":"Neurologia medico-chirurgica","url":"https://pubmed.ncbi.nlm.nih.gov/11803583","citation_count":25,"is_preprint":false},{"pmid":"30094060","id":"PMC_30094060","title":"Tissue engineering using 3D printed nano-bioactive glass loaded with NELL1 gene for repairing alveolar bone defects.","date":"2018","source":"Regenerative biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/30094060","citation_count":25,"is_preprint":false},{"pmid":"25376942","id":"PMC_25376942","title":"Proliferation and osteogenic differentiation of mesenchymal stem cells induced by a short isoform of NELL-1.","date":"2015","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/25376942","citation_count":25,"is_preprint":false},{"pmid":"22728432","id":"PMC_22728432","title":"The C-terminal region of NELL1 mediates osteoblastic cell adhesion through integrin α3β1.","date":"2012","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/22728432","citation_count":24,"is_preprint":false},{"pmid":"25220281","id":"PMC_25220281","title":"Effect of NELL1 gene overexpression in iPSC-MSCs seeded on calcium phosphate cement.","date":"2014","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/25220281","citation_count":23,"is_preprint":false},{"pmid":"21931789","id":"PMC_21931789","title":"NELL-1, an osteoinductive factor, is a direct transcriptional target of Osterix.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21931789","citation_count":22,"is_preprint":false},{"pmid":"23264108","id":"PMC_23264108","title":"Expression and localization of Nell-1 during murine molar development.","date":"2012","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/23264108","citation_count":21,"is_preprint":false},{"pmid":"29288032","id":"PMC_29288032","title":"Chitosan-stablized bovine serum albumin nanoparticles having ability to control the release of NELL-1 protein.","date":"2017","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/29288032","citation_count":21,"is_preprint":false},{"pmid":"23017834","id":"PMC_23017834","title":"Lentiviral-mediated gene transfer into human adipose-derived stem cells: role of NELL1 versus BMP2 in osteogenesis and adipogenesis in vitro.","date":"2012","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/23017834","citation_count":20,"is_preprint":false},{"pmid":"28614787","id":"PMC_28614787","title":"NELL-1 induces Sca-1+ mesenchymal progenitor cell expansion in models of bone maintenance and repair.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/28614787","citation_count":20,"is_preprint":false},{"pmid":"25913252","id":"PMC_25913252","title":"Pharmacokinetics and osteogenic potential of PEGylated NELL-1 in vivo after systemic administration.","date":"2015","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/25913252","citation_count":19,"is_preprint":false},{"pmid":"27113550","id":"PMC_27113550","title":"Vertebral Implantation of NELL-1 Enhances Bone Formation in an Osteoporotic Sheep Model.","date":"2016","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/27113550","citation_count":19,"is_preprint":false},{"pmid":"33866674","id":"PMC_33866674","title":"Posttransplant nephrotic syndrome resulting from NELL1-positive membranous nephropathy.","date":"2021","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/33866674","citation_count":18,"is_preprint":false},{"pmid":"30272321","id":"PMC_30272321","title":"DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients.","date":"2018","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/30272321","citation_count":18,"is_preprint":false},{"pmid":"35700263","id":"PMC_35700263","title":"NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression.","date":"2022","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/35700263","citation_count":17,"is_preprint":false},{"pmid":"21814724","id":"PMC_21814724","title":"Efficient production and characterization of recombinant human NELL1 protein in human embryonic kidney 293-F cells.","date":"2012","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/21814724","citation_count":17,"is_preprint":false},{"pmid":"34647317","id":"PMC_34647317","title":"NELL1 augments osteogenesis and inhibits inflammation of human periodontal ligament stem cells induced by BMP9.","date":"2022","source":"Journal of periodontology","url":"https://pubmed.ncbi.nlm.nih.gov/34647317","citation_count":16,"is_preprint":false},{"pmid":"24563467","id":"PMC_24563467","title":"Oligomerization-induced conformational change in the C-terminal region of Nel-like molecule 1 (NELL1) protein is necessary for the efficient mediation of murine MC3T3-E1 cell adhesion and spreading.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24563467","citation_count":16,"is_preprint":false},{"pmid":"33905072","id":"PMC_33905072","title":"Nell-1 attenuates lipopolysaccharide-induced inflammation in human dental pulp cells.","date":"2021","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/33905072","citation_count":16,"is_preprint":false},{"pmid":"24818884","id":"PMC_24818884","title":"Bioactivity and circulation time of PEGylated NELL-1 in mice and the potential for osteoporosis therapy.","date":"2014","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/24818884","citation_count":16,"is_preprint":false},{"pmid":"31582804","id":"PMC_31582804","title":"Cumulative inactivation of Nell-1 in Wnt1 expressing cell lineages results in craniofacial skeletal hypoplasia and postnatal hydrocephalus.","date":"2019","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/31582804","citation_count":15,"is_preprint":false},{"pmid":"30628703","id":"PMC_30628703","title":"Effect of NELL1 on lung cancer stem‑like cell differentiation.","date":"2019","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/30628703","citation_count":14,"is_preprint":false},{"pmid":"32454289","id":"PMC_32454289","title":"The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/32454289","citation_count":14,"is_preprint":false},{"pmid":"30979495","id":"PMC_30979495","title":"Nell-1 promotes the neural-like differentiation of dental pulp cells.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30979495","citation_count":14,"is_preprint":false},{"pmid":"31337284","id":"PMC_31337284","title":"Synergistic Effect of NELL-1 and an Ultra-Low Dose of BMP-2 on Spinal Fusion.","date":"2019","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/31337284","citation_count":14,"is_preprint":false},{"pmid":"29694513","id":"PMC_29694513","title":"miR-27a protects human mitral valve interstitial cell from TNF-α-induced inflammatory injury via up-regulation of NELL-1.","date":"2018","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/29694513","citation_count":13,"is_preprint":false},{"pmid":"37078902","id":"PMC_37078902","title":"Mercury-associated neural epidermal growth factor-like 1 protein (NELL-1) positive membranous nephropathy after use of skin lightening creams.","date":"2023","source":"Clinical toxicology (Philadelphia, Pa.)","url":"https://pubmed.ncbi.nlm.nih.gov/37078902","citation_count":13,"is_preprint":false},{"pmid":"29294300","id":"PMC_29294300","title":"The Effects of Systemic Therapy of PEGylated NEL-Like Protein 1 (NELL-1) on Fracture Healing in Mice.","date":"2017","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/29294300","citation_count":13,"is_preprint":false},{"pmid":"28380437","id":"PMC_28380437","title":"NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28380437","citation_count":12,"is_preprint":false},{"pmid":"30352124","id":"PMC_30352124","title":"Inactivation of Nell-1 in Chondrocytes Significantly Impedes Appendicular Skeletogenesis.","date":"2018","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/30352124","citation_count":12,"is_preprint":false},{"pmid":"25791475","id":"PMC_25791475","title":"NELL-1 expression in benign and malignant bone tumors.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25791475","citation_count":12,"is_preprint":false},{"pmid":"33072736","id":"PMC_33072736","title":"Activation of Nell-1 in BMSC Sheet Promotes Implant Osseointegration Through Regulating Runx2/Osterix Axis.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33072736","citation_count":12,"is_preprint":false},{"pmid":"30356449","id":"PMC_30356449","title":"Optimizing Osteogenic Differentiation of Ovine Adipose-Derived Stem Cells by Osteogenic Induction Medium and FGFb, BMP2, or NELL1 In Vitro.","date":"2018","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/30356449","citation_count":11,"is_preprint":false},{"pmid":"26627376","id":"PMC_26627376","title":"Mapping the heparin-binding site of the osteoinductive protein NELL1 by site-directed mutagenesis.","date":"2015","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/26627376","citation_count":11,"is_preprint":false},{"pmid":"26090379","id":"PMC_26090379","title":"MALDI-TOF Mass Array Analysis of Nell-1 Promoter Methylation Patterns in Human Gastric Cancer.","date":"2015","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/26090379","citation_count":11,"is_preprint":false},{"pmid":"27047227","id":"PMC_27047227","title":"NELL-1 expression in tumors of cartilage.","date":"2015","source":"Journal of orthopaedics","url":"https://pubmed.ncbi.nlm.nih.gov/27047227","citation_count":9,"is_preprint":false},{"pmid":"27349789","id":"PMC_27349789","title":"Controlled release of NELL-1 protein from chitosan/hydroxyapatite-modified TCP particles.","date":"2016","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/27349789","citation_count":9,"is_preprint":false},{"pmid":"27354930","id":"PMC_27354930","title":"Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.","date":"2016","source":"BioResearch open access","url":"https://pubmed.ncbi.nlm.nih.gov/27354930","citation_count":9,"is_preprint":false},{"pmid":"34201046","id":"PMC_34201046","title":"NELL-1 Increased the Osteogenic Differentiation and mRNA Expression of Spheroids Composed of Stem Cells.","date":"2021","source":"Medicina (Kaunas, Lithuania)","url":"https://pubmed.ncbi.nlm.nih.gov/34201046","citation_count":8,"is_preprint":false},{"pmid":"37007702","id":"PMC_37007702","title":"Backtracking cryptic recurrence of esophageal cancer from membranous nephropathy: the detection of glomerular NELL-1 and IgG4.","date":"2022","source":"Clinical kidney journal","url":"https://pubmed.ncbi.nlm.nih.gov/37007702","citation_count":8,"is_preprint":false},{"pmid":"38908089","id":"PMC_38908089","title":"Neural epidermal growth factor-like 1 protein (Nell-1) alleviates periodontal tissue destruction in periodontitis by regulating the ratio of M2/M1 macrophage phenotypes.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38908089","citation_count":7,"is_preprint":false},{"pmid":"34512380","id":"PMC_34512380","title":"Novel Molecule Nell-1 Promotes the Angiogenic Differentiation of Dental Pulp Stem Cells.","date":"2021","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34512380","citation_count":7,"is_preprint":false},{"pmid":"38596642","id":"PMC_38596642","title":"NELL1 membranous nephropathy: clinical associations provide mechanistic clues.","date":"2024","source":"Frontiers in nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/38596642","citation_count":6,"is_preprint":false},{"pmid":"24335144","id":"PMC_24335144","title":"Human NELL1 protein augments constructive tissue remodeling with biologic scaffolds.","date":"2013","source":"Cells, tissues, organs","url":"https://pubmed.ncbi.nlm.nih.gov/24335144","citation_count":6,"is_preprint":false},{"pmid":"30091681","id":"PMC_30091681","title":"Association of DFNA5, SYK, and NELL1 variants along with HPV infection in oral cancer among the prolonged tobacco-chewers.","date":"2018","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30091681","citation_count":6,"is_preprint":false},{"pmid":"22404332","id":"PMC_22404332","title":"NELL1 promotes bone regeneration in polyethylene particle-induced osteolysis.","date":"2012","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/22404332","citation_count":5,"is_preprint":false},{"pmid":"36817287","id":"PMC_36817287","title":"NELL1-Positive HIV-Associated Lupus-Like Membranous Nephropathy with Spontaneous Remission.","date":"2022","source":"Glomerular diseases","url":"https://pubmed.ncbi.nlm.nih.gov/36817287","citation_count":5,"is_preprint":false},{"pmid":"27080300","id":"PMC_27080300","title":"[NELL-1: a novel highly efficient and specific growth factor].","date":"2016","source":"Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27080300","citation_count":5,"is_preprint":false},{"pmid":"37122392","id":"PMC_37122392","title":"Anti-PLA2R Antibody Development During NELL1-Associated Membranous Glomerulonephritis Treatment: A Case Report.","date":"2023","source":"Kidney medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37122392","citation_count":5,"is_preprint":false},{"pmid":"29388706","id":"PMC_29388706","title":"Nell-1-ΔE, a novel transcript of Nell-1, inhibits cell migration by interacting with enolase-1.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29388706","citation_count":5,"is_preprint":false},{"pmid":"19493425","id":"PMC_19493425","title":"An ectopic study of tissue-engineered bone with Nell-1 gene modified rat bone marrow stromal cells in nude mice.","date":"2009","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19493425","citation_count":5,"is_preprint":false},{"pmid":"30899146","id":"PMC_30899146","title":"Age dependent effects of NELL-1 isoforms on bone marrow stromal cells.","date":"2019","source":"Journal of orthopaedics","url":"https://pubmed.ncbi.nlm.nih.gov/30899146","citation_count":4,"is_preprint":false},{"pmid":"40541723","id":"PMC_40541723","title":"Detection and characterization of NELL1 autoantibodies in NELL1 positive membranous nephropathy.","date":"2025","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/40541723","citation_count":3,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54815,"output_tokens":7892,"usd":0.141412,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17463,"output_tokens":5463,"usd":0.111945,"stage2_stop_reason":"end_turn"},"total_usd":0.253357,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"NELL1 and NELL2 proteins expressed in COS-7 cells are homotrimeric glycoproteins with heparin-binding activity, contain an N-terminal thrombospondin-1-like module, five von Willebrand factor C domains, and six EGF-like domains, and are partially secreted into culture medium while showing distinct subcellular cytoplasmic localization.\",\n      \"method\": \"Recombinant protein expression in COS-7 cells, biochemical characterization (heparin-binding assay, glycoprotein analysis)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro biochemical reconstitution in COS-7 cells with functional characterization, single lab, single study\",\n      \"pmids\": [\"10548494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"NELL1 mRNA is specifically expressed in neural tissue and in mesenchymal cells/osteoblasts at osteogenic fronts of prematurely fusing cranial sutures, and is upregulated in unilateral coronal synostosis; its expression is largely absent in tibiae and fibroblast cultures but present in rat calvarial osteoprogenitor cells.\",\n      \"method\": \"In situ hybridization, Northern blot (multiorgan tissue mRNA blot), RT-PCR in rat calvarial cells\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization experiment with tissue context, replicated across human and rat tissues in single study\",\n      \"pmids\": [\"9893069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Overexpression of Nell-1 in transgenic mice is sufficient to induce craniosynostosis-like phenotypes, accelerate calvarial osteoblast differentiation and mineralization, and promote alkaline phosphatase expression and micronodule formation in vitro; conversely, Nell-1 downregulation inhibits osteoblast differentiation in vitro.\",\n      \"method\": \"Transgenic mouse overexpression model, in vitro calvarial osteoblast culture with Nell-1 overexpression/knockdown, histology, alkaline phosphatase assay\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function and gain-of-function with specific cellular phenotype, replicated in vivo and in vitro, multiple orthogonal methods\",\n      \"pmids\": [\"12235118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Overexpression of Nell-1 induces apoptosis specifically in osteoblastic cells (not in NIH3T3 fibroblasts), associated with modulation of apoptosis-related genes; the craniosynostosis mouse model overexpressing Nell-1 showed increased apoptosis in calvaria.\",\n      \"method\": \"Viral transduction, recombinant protein treatment, apoptosis assays, gene expression analysis in osteoblastic cells and primary fibroblasts, in vivo mouse model\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO/OE with defined cellular phenotype and cell-type specificity, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"14672347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Nell-1 deficiency (ENU-induced Cys502Ter truncation) in mice results in cranial and vertebral skeletal defects and is associated with reduced expression of extracellular matrix genes critical for chondrogenesis and osteogenesis, revealing a role for Nell1 in signal transduction in both intramembranous and endochondral ossification.\",\n      \"method\": \"ENU mutagenesis, positional cloning, real-time quantitative RT-PCR of 219 genes, skeletal phenotyping\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function mouse model with defined molecular and phenotypic readouts, multiple orthogonal methods\",\n      \"pmids\": [\"16537572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Nell-1 overexpression during embryonic development induces acrania via massive apoptosis in calvarial osteoblasts and neural cells, associated with increased Fas and Fas-L production; transgenic mice also showed premature hypertrophy and increased apoptosis of chondrocytes.\",\n      \"method\": \"Transgenic mouse embryo analysis, apoptosis assays, immunostaining for Fas/Fas-L, in vitro primary chondrocyte AdNell-1 transduction\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic model with defined molecular mechanism (Fas/Fas-L), validated in vitro, single lab\",\n      \"pmids\": [\"16652108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NELL1 protein transiently activates the MAPK signaling cascade, induces phosphorylation of Runx2, and promotes rapid intracellular accumulation of Tyr-phosphorylated proteins in osteoblastic cells; unlike BMP2, NELL1 does not activate the Smad signaling cascade.\",\n      \"method\": \"In vitro signaling assays (MAPK activation, phospho-protein analysis, Smad pathway assay) in osteoblastic cells treated with recombinant NELL1 protein\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro signaling assay with negative control (Smad), multiple pathway readouts, single lab\",\n      \"pmids\": [\"18082140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Runx2 directly binds to three OSE2 elements in the NELL-1 promoter and transactivates NELL-1 expression; forced Runx2 expression induces NELL-1 in rat calvarial cells and rescues NELL-1 expression in Runx2-null calvarial cells.\",\n      \"method\": \"Promoter-luciferase reporter assays, gel shift/supershift with Runx2 antibodies, ChIP assay, site-directed mutagenesis, RT-PCR in Runx2 null cells\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — promoter mutagenesis, EMSA, ChIP, and functional rescue in Runx2-null cells; multiple orthogonal methods\",\n      \"pmids\": [\"17042739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Nell-1 and BMP-2 synergistically enhance osteogenic differentiation of C2C12 myoblasts and activate the JNK MAPK pathway; Nell-1 alone does not induce osteogenic differentiation of myoblasts, demonstrating osteochondral lineage specificity.\",\n      \"method\": \"Adenoviral transduction of C2C12 myoblasts, alkaline phosphatase activity, osteopontin production, MAPK signaling analysis (JNK, p38, ERK1/2), nude mouse muscle injection model\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD/OE with specific cellular phenotype and pathway placement (JNK specificity), in vivo validation, single lab\",\n      \"pmids\": [\"17352654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NELL-1 directly binds to extracellular Integrinβ1, induces focal adhesion, and promotes cell adherence; siRNA knockdown of Integrinβ1 abolishes NELL-1-mediated cell surface binding and enhanced cell attachment.\",\n      \"method\": \"Co-immunoprecipitation (NELL-1 binding to Integrinβ1), siRNA knockdown, cell adhesion assays in multiple cell lines, PLGA scaffold pre-coating experiments\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — receptor identification by Co-IP with siRNA validation and functional consequence (cell adhesion), single lab, multiple cell lines\",\n      \"pmids\": [\"22807400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NELL-1 is a direct transcriptional target of Osterix, which suppresses NELL-1 expression by binding to Sp1 sites in the NELL-1 promoter; knockdown of Osterix increases NELL-1 transcription and osteoblastic differentiation.\",\n      \"method\": \"Promoter-luciferase reporter assays, site-directed mutagenesis (Sp1 sites), EMSA, ChIP assay in Saos-2 cells and primary human osteoblasts, siRNA knockdown of Osterix\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — promoter mutagenesis, EMSA, ChIP, and siRNA knockdown with functional readout; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"21931789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nell-1 is a critical downstream mediator of Runx2: Nell-1 signaling activates ERK1/2 and JNK1 MAPK pathways and enhances Runx2 phosphorylation; genetic rescue experiments showed Nell-1 can partially rescue calvarial defects in Runx2 haploinsufficient mice, but requires at least one Runx2 allele for mineralization.\",\n      \"method\": \"CMV-Nell-1 × Runx2+/- cross-mating, siRNA knockdown of Nell-1, ENU-induced Nell-1-/- calvarial cells, MAPK pathway analysis, calvarial explant bone formation assays\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in multiple mouse models, MAPK signaling pathway placement, siRNA knockdown with defined phenotype; multiple orthogonal methods\",\n      \"pmids\": [\"20939017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nfatc2 is a primary response gene of Nell-1 in chondrocytes; Nell-1 transiently induces Nfatc2 transcription and translation through a Runx2-dependent mechanism, and siRNA knockdown of Nfatc2 reverses Nell-1's inhibitory effects on chondrocyte differentiation.\",\n      \"method\": \"Microarray screen, real-time PCR validation, dominant-negative Runx2 adenoviral transduction, siRNA knockdown of Nfatc2, ATDC5 and primary mouse chondrocyte assays, immunohistochemistry in wild-type and Nell1-deficient mouse femurs\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — microarray with validation, dominant-negative epistasis, siRNA rescue, in vivo corroboration; multiple orthogonal methods in single study\",\n      \"pmids\": [\"21611965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NELL-1 binds to APR3 (apoptosis related protein 3), a membrane proliferation suppressor; NELL-1 and APR3 co-localize on the nuclear envelope of human osteoblasts, and NELL-1 inhibits osteoblast proliferation via APR3 through down-regulation of Cyclin D1; RNAi of APR3 significantly reduces the differentiation effect of NELL-1.\",\n      \"method\": \"Biopanning for NELL-1 binding proteins, co-localization (immunofluorescence), co-transfection experiments, RNAi of APR3, osteogenic differentiation and proliferation assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — biopanning identification of binding partner, co-localization, and RNAi validation with functional readout; single lab but multiple methods\",\n      \"pmids\": [\"21723284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The C-terminal region of NELL1 mediates osteoblastic cell adhesion through integrin α3β1; function-blocking antibodies against integrin α3 and β1 subunits strongly inhibit cell adhesion to NELL1, and focal adhesion kinase (FAK) activation is involved in NELL1 signaling.\",\n      \"method\": \"Series of recombinant NELL1 deletion and domain-mapping proteins, function-blocking antibody experiments, FAK activation assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic domain deletion mutagenesis, blocking antibody inhibition, FAK signaling readout; single lab\",\n      \"pmids\": [\"22728432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NELL1-mediated cell adhesion and spreading requires oligomerization: a cysteine-to-serine mutant NELL1 that cannot form homo-oligomers shows substantially lower cell adhesion activity; an oligomerization-induced conformational change in the C-terminal cysteine-rich region is critical for NELL1 adhesive function.\",\n      \"method\": \"Recombinant NELL1 proteins (intact, deleted, cysteine-mutant), reducing agent treatment, site-directed cysteine-to-serine mutagenesis at coiled-coil domain, cell adhesion assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic structure-function mutagenesis with reconstituted proteins, multiple deletion and point mutants tested, mechanistic conformational change identified\",\n      \"pmids\": [\"24563467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NELL1 binds to cell surface proteoglycans through its N-terminal thrombospondin-1-like (TSPN) domain; mutational analysis of predicted heparin-binding sites on a 3D structural model of the TSPN domain confirmed that heparin-binding activity of this domain mediates interaction with cell surface proteoglycans.\",\n      \"method\": \"Site-directed mutagenesis of TSPN domain heparin-binding sites, 3D structural modeling, cell surface proteoglycan binding assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-directed mutagenesis with functional binding assay, structural model guidance; single lab\",\n      \"pmids\": [\"26627376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Recombinant NELL-1 binds to integrin β1 and induces Wnt/β-catenin signaling, which is associated with increased osteoblast differentiation and inhibition of osteoclast-directed bone resorption; Nell-1-haploinsufficient mice develop age-related osteoporosis with a reduced osteoblast:osteoclast ratio.\",\n      \"method\": \"Recombinant protein binding assay (integrin β1), Wnt/β-catenin signaling analysis, Nell-1 haploinsufficient mouse model, systemic NELL-1 delivery in gonadectomy-induced osteoporotic mice and sheep\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — receptor binding with downstream pathway (Wnt/β-catenin), loss-of-function mouse model with specific phenotype, confirmed in large animal model; multiple orthogonal methods\",\n      \"pmids\": [\"26082355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NELL-1 increases pre-osteoblast mineralization through activation of both phosphate transporter Pit1 and Pit2; neutralizing antibodies against Pit-1 and Pit-2 completely abrogate NELL-1-induced Pi influx, distinguishing NELL-1 from BMP-2 which uses only Pit-1.\",\n      \"method\": \"Recombinant NELL-1 and BMP-2 treatment of MC3T3-E1 pre-osteoblasts, intracellular Pi quantification (malachite green), Pit-1/Pit-2 expression analysis, neutralizing antibodies\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — neutralizing antibody functional blockade identifies specific transporters, mechanistic distinction from BMP-2 established; single lab\",\n      \"pmids\": [\"22580275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NELL-1 suppresses BMP2-induced NF-κB transcriptional activity and generation of reactive oxygen species (ROS) in fibroblasts, attenuating BMP2-induced inflammation (TNFα, IL6) both locally and systemically in rats.\",\n      \"method\": \"In vivo rat femoral bone onlay with histology, immunohistochemistry, real-time PCR, ELISA for TNFα/IL6; in vitro NIH3T3 cell assays for NF-κB activity and ROS\",\n      \"journal\": \"Tissue engineering. Part A\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro validation with specific molecular mechanism (NF-κB, ROS), multiple readouts; single lab\",\n      \"pmids\": [\"23758588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NELL-1 induces Sca-1 transcription in mesenchymal progenitor cells (MPCs) in a process requiring intact Wnt/β-catenin signaling; Nell-1 haploinsufficiency reduces Sca-1+CD45-CD31- bone marrow MPCs, while systemic rhNELL-1 administration increases this population.\",\n      \"method\": \"Nell-1 haploinsufficient mouse analysis (flow cytometry), systemic rhNELL-1 administration, Wnt/β-catenin pathway inhibition, nonhuman primate spinal fusion model\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function and pharmacological gain-of-function with pathway inhibition (Wnt/β-catenin required), multiple animal models; single lab\",\n      \"pmids\": [\"28614787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Chondrocyte-specific inactivation of Nell-1 (Col2α1-Cre) impedes appendicular skeletogenesis and osteoporosis through inhibition of Ihh signaling and alteration of the Ihh-PTHrP feedback loop; exogenous Nell-1 protein partially rescues decreased proliferation/differentiation of Nell-1-deficient chondrocytes, and this rescue is diminished by Ihh signaling inhibitors (cyclopamine or GANT61).\",\n      \"method\": \"Conditional knockout mice (Nell-1flox/flox; Col2α1-Cre+), micro-CT, histomorphometry, immunohistochemistry (Ihh, Patched-1, PTHrP, PTHrP receptor, Gli-1), Ihh inhibitor rescue experiments\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific knockout with defined signaling pathway (Ihh-PTHrP), pharmacological pathway inhibition confirmation, multiple orthogonal methods\",\n      \"pmids\": [\"30352124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Neural crest cell (Wnt1 lineage)-specific Nell-1 inactivation causes frontonasal and mandibular bone defects with decreased Wnt/β-catenin markers; Nell-1-deficient cranial neural crest cells (CNCCs) show reduced proliferation and osteogenic differentiation, and exogenous Nell-1 rescues active-β-catenin levels and osteogenic capacity.\",\n      \"method\": \"Nell-1flox/flox; Wnt1-Cre conditional knockout mice, lineage tracing, immunostaining (Osteocalcin, active-β-catenin), primary CNCC culture with Nell-1 protein rescue\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with lineage tracing, protein rescue experiment, Wnt/β-catenin pathway linkage; multiple orthogonal methods\",\n      \"pmids\": [\"31582804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A specific receptor for NELL-1 in osteogenesis was identified as contactin-associated protein-like 4 (Cntnap4); NELL-1 signaling involves MAPK and Wnt/β-catenin pathways with key regulatory roles for Runx2.\",\n      \"method\": \"Cited in review as identified receptor (Cntnap4 for osteogenesis); supporting MAPK and Wnt/β-catenin pathway data from referenced primary studies\",\n      \"journal\": \"Journal of dental research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — receptor identification (Cntnap4) cited in a review without primary experimental detail in this abstract; cannot confirm tier from available text\",\n      \"pmids\": [\"31610747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NELL-1 inhibits adipogenic differentiation and increases expression of Hedgehog signaling markers (Ihh, Gli1, Ptc1); co-application of the Smoothened antagonist Cyclopamine reverses the pro-osteogenic effect of NELL-1, indicating NELL-1's anti-adipogenic effect is partly Hedgehog-dependent.\",\n      \"method\": \"Adenoviral NELL-1 delivery and recombinant NELL-1 protein in 3T3-L1 and human adipose-derived stromal cells, hedgehog pathway inhibitor (Cyclopamine) blockade, oil red O staining, gene expression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway inhibition (Cyclopamine reversal) with gene expression readout; single lab, two orthogonal methods\",\n      \"pmids\": [\"21723263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Nell-1 enhances osteogenic differentiation of pre-osteoblasts on titanium surfaces via activation of MAPK/ERK (and JNK) signaling; ERK inhibitor U0126 suppresses the promotive effect of Nell-1 on most osteogenic markers.\",\n      \"method\": \"Recombinant Nell-1 treatment of MC3T3-E1 on Ti surfaces, Western blot for MAPK pathway, ERK inhibitor U0126 blockade, ALP assay, ELISA, RT-PCR\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibitor (U0126) reversal identifies ERK pathway requirement; single lab, multiple readouts\",\n      \"pmids\": [\"30359975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A novel NELL-1 transcript (Nell-1-ΔE) lacking one EGF-like domain, but not full-length Nell-1, inhibits cell migration by interacting with enolase-1 (ENO-1) in the extracellular space; this interaction was confirmed by co-immunoprecipitation and LC/MS-MS.\",\n      \"method\": \"Homology modeling, recombinant protein production, Co-IP/LC-MS-MS identification of ENO-1 as Nell-1-ΔE binding partner, wound healing assay in ENO-1-overexpressing cells\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP/MS identification of binding partner with functional wound-healing assay validation; single lab\",\n      \"pmids\": [\"29388706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Genetic deletion of NELL1 in osteosarcoma cell lines reduces invasive behavior and FAK signaling; transcriptomic and phosphoproteomic analyses show NELL1 loss skews matricellular protein expression; culturing NELL1-knockout sarcoma cells on wild-type OS-enriched matricellular proteins reverses the phenotypic and signaling changes.\",\n      \"method\": \"NELL1 genetic deletion in human OS cell lines, xenograft mouse model, conditional Nell1 knockout in p53/Rb-driven sarcomagenesis mouse model, transcriptomics, phosphoproteomics, ECM rescue experiment\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with defined FAK signaling mechanism, ECM rescue experiment, validated in human and mouse models; multiple orthogonal methods\",\n      \"pmids\": [\"35700263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Nell-1 promotes macrophage polarization from M1 to M2 phenotype through the JNK/MAPK signaling pathway; JNK inhibitor SP600125 reverses Nell-1's effect on macrophage polarization in LPS-stimulated RAW 264.7 cells.\",\n      \"method\": \"LPS-stimulated RAW 264.7 macrophages treated with Nell-1 protein, JNK inhibitor SP600125 blockade, RT-PCR, Western blot, flow cytometry for M1/M2 markers; rat ligation-induced periodontitis model\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibitor reversal (JNK inhibitor) identifies specific pathway, in vivo and in vitro validation; single lab\",\n      \"pmids\": [\"38908089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NELL1 reduces colony formation, invasion, and chemotherapeutic resistance of lung cancer stem-like cells, associated with reduced phospho-MET, Notch3, and HES1 expression, suggesting NELL1 induces differentiation by inhibiting c-MET-Notch signaling.\",\n      \"method\": \"NELL1 overexpression in 95-D lung cancer stem-like cells, soft agar colony formation, invasion assay, cell proliferation assay with carboplatin/cisplatin, Western blot for p-MET/Notch3/HES1\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single gene overexpression with pathway marker readout but no inhibitor/rescue validation; single lab, single method per endpoint\",\n      \"pmids\": [\"30628703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NELL1 is expressed in glomeruli and detected as a target antigen in membranous nephropathy; IgG co-localizes with NELL1 along the glomerular basement membrane, and patients have serum anti-NELL1 antibodies reactive by Western blot.\",\n      \"method\": \"Laser microdissection/mass spectrometry of glomeruli, immunohistochemistry, confocal microscopy co-localization, Western blot with patient sera\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — antigen discovery by mass spectrometry validated by IHC, co-localization, and serology across multiple patient cohorts; replicated in validation cohorts\",\n      \"pmids\": [\"31901340\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NELL1 is a secreted homotrimeric glycoprotein that functions as an osteoinductive growth factor downstream of the Runx2/Osterix transcriptional axis; it signals through integrin β1 (and integrin α3β1) to activate MAPK (ERK1/2, JNK1) pathways, promote Wnt/β-catenin signaling, and phosphorylate Runx2, thereby driving osteoblast differentiation and inhibiting adipogenesis, osteoclastogenesis, and inflammation; in chondrocytes it regulates the Ihh-PTHrP feedback loop via Nfatc2; it binds heparin/proteoglycans through its TSPN domain and requires oligomerization for efficient cell adhesion; additionally, it functions as an autoantigen in a subset of membranous nephropathy where circulating anti-NELL1 IgG1 antibodies drive glomerular immune-complex deposition, and in osteosarcoma it modulates the ECM matrisome to promote FAK-dependent invasion.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NELL1 is a secreted homotrimeric, heparin-binding glycoprotein that acts as an osteoinductive signaling molecule controlling skeletal cell fate during both intramembranous and endochondral ossification [#0, #4]. Its expression is restricted to neural tissue and osteogenic fronts, where it is concentrated in mesenchymal/osteoblast lineages at cranial sutures [#1]. NELL1 sits downstream of the master osteoblast transcription factor axis: Runx2 directly binds OSE2 elements in the NELL1 promoter to activate transcription, while Osterix represses it through Sp1 sites, placing NELL1 under bidirectional transcriptional control [#7, #10]. Gain- and loss-of-function mouse models establish that NELL1 dosage is sufficient and required for normal skeletogenesis, with overexpression driving craniosynostosis-like phenotypes and accelerated osteoblast differentiation and deficiency producing cranial and vertebral defects [#2, #4]. Functionally, NELL1 engages cell-surface receptors—integrin β1 and integrin α3β1—to nucleate focal adhesions and activate FAK, and signals through MAPK (ERK1/2, JNK1) cascades that feed back to phosphorylate Runx2, while sparing the Smad pathway used by BMP2 [#9, #11, #14, #6]. Downstream of receptor engagement, NELL1 promotes Wnt/β-catenin signaling to expand osteogenic progenitors and tip the osteoblast:osteoclast balance toward bone formation, with haploinsufficient mice developing age-related osteoporosis [#17, #20]. NELL1 also acts as a checkpoint between lineages: it inhibits adipogenesis through Hedgehog signaling and, in chondrocytes, induces Nfatc2 in a Runx2-dependent manner and modulates the Ihh–PTHrP feedback loop to govern chondrocyte proliferation and differentiation [#24, #12, #21]. Adhesive activity requires cysteine-dependent oligomerization, and proteoglycan binding is mediated by heparin-binding sites in the N-terminal TSPN domain [#15, #16]. Beyond skeletal biology, NELL1 is a glomerular target autoantigen in membranous nephropathy, where patient IgG co-localizes with NELL1 along the glomerular basement membrane [#30], and in osteosarcoma NELL1 shapes the matricellular environment to sustain FAK-dependent invasion [#27].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established NELL1's molecular nature—answering what kind of protein it is—by showing it is a secreted, homotrimeric, heparin-binding glycoprotein built from TSPN, von Willebrand C, and EGF-like modules expressed selectively in neural and cranial osteogenic tissue.\",\n      \"evidence\": \"Recombinant expression in COS-7 cells with biochemical characterization, plus in situ hybridization/Northern/RT-PCR across human and rat tissues\",\n      \"pmids\": [\"10548494\", \"9893069\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No receptor or signaling pathway identified at this stage\", \"Functional consequence of secretion not tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrated NELL1 is a functional regulator of osteoblast differentiation in vivo, resolving whether its restricted expression was causal—transgenic overexpression drives craniosynostosis and accelerated mineralization while knockdown blocks differentiation.\",\n      \"evidence\": \"Transgenic mouse overexpression and in vitro calvarial osteoblast culture with overexpression/knockdown, histology and ALP assays\",\n      \"pmids\": [\"12235118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling mechanism and receptor unknown\", \"Did not distinguish direct osteoinduction from apoptosis-mediated remodeling\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined NELL1's requirement and apoptotic activity in skeletal patterning—loss-of-function causes cranial/vertebral defects with reduced ECM gene expression, while excess NELL1 triggers Fas/Fas-L-dependent apoptosis of osteoblasts and chondrocytes.\",\n      \"evidence\": \"ENU-induced truncation mouse, positional cloning, qRT-PCR of 219 genes, transgenic embryo apoptosis analysis with Fas/Fas-L immunostaining\",\n      \"pmids\": [\"16537572\", \"16652108\", \"14672347\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target driving ECM gene changes not identified\", \"Apoptotic mechanism cell-type specificity not fully explained\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Placed NELL1 within the osteoblast transcriptional hierarchy and its proximal signaling output—Runx2 directly transactivates NELL1, and NELL1 in turn activates MAPK and phosphorylates Runx2 without engaging Smad, distinguishing it from BMP2.\",\n      \"evidence\": \"Promoter-luciferase, EMSA, ChIP, rescue in Runx2-null cells; in vitro MAPK and Smad signaling assays with recombinant NELL1; C2C12 synergy with BMP2\",\n      \"pmids\": [\"17042739\", \"18082140\", \"17352654\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-surface receptor mediating MAPK activation not yet identified\", \"Mechanism of Runx2 phosphorylation feedback unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified NELL1 cell-surface receptors and downstream effectors, answering how the secreted protein transduces signal—it binds integrin β1, activates ERK1/2 and JNK1 to phosphorylate Runx2, is repressed by Osterix, and induces chondrocyte Nfatc2 in a Runx2-dependent manner.\",\n      \"evidence\": \"Co-IP and siRNA for integrin β1; genetic epistasis in Runx2+/- and Nell1-/- mice; Osterix promoter ChIP/EMSA/siRNA; microarray with Nfatc2 siRNA rescue and APR3 biopanning\",\n      \"pmids\": [\"22807400\", \"20939017\", \"21931789\", \"21611965\", \"21723284\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether integrin β1 is the sole or primary receptor unresolved\", \"Structural basis of receptor engagement unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Resolved the adhesion receptor and lineage-balancing functions—NELL1's C-terminus mediates adhesion through integrin α3β1 with FAK activation, it activates phosphate transporters Pit1/Pit2 distinct from BMP2, and inhibits adipogenesis via Hedgehog signaling.\",\n      \"evidence\": \"Domain-mapping deletion proteins and α3/β1 blocking antibodies with FAK assay; Pi influx with Pit-1/Pit-2 neutralizing antibodies; Cyclopamine reversal in adipose-derived stromal cells\",\n      \"pmids\": [\"22728432\", \"22580275\", \"21723263\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship between integrin α3β1 and β1 receptor reports not reconciled\", \"Direct Hedgehog ligand interaction not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined the structural requirement for NELL1 adhesion—cysteine-dependent oligomerization producing a conformational change in the C-terminal cysteine-rich region is essential, and TSPN heparin-binding sites mediate proteoglycan engagement.\",\n      \"evidence\": \"Systematic deletion/cysteine-to-serine mutagenesis with reducing-agent and adhesion assays; TSPN domain heparin-binding site mutagenesis guided by 3D modeling\",\n      \"pmids\": [\"24563467\", \"26627376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No experimental atomic structure of full-length oligomer\", \"How oligomerization couples to receptor activation not shown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Linked NELL1 receptor binding to Wnt/β-catenin output and systemic bone homeostasis—integrin β1 binding induces Wnt/β-catenin signaling that favors osteoblasts over osteoclasts, with haploinsufficiency causing osteoporosis.\",\n      \"evidence\": \"Recombinant integrin β1 binding and Wnt/β-catenin analysis, Nell1 haploinsufficient mouse, systemic delivery in osteoporotic mice and sheep\",\n      \"pmids\": [\"26082355\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic link from integrin engagement to Wnt activation not detailed\", \"Receptor for Wnt induction versus adhesion not separated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Connected NELL1 to progenitor pool expansion—NELL1 induces Sca-1 in mesenchymal progenitors through Wnt/β-catenin, and dosage controls the marrow MPC population.\",\n      \"evidence\": \"Haploinsufficient mouse flow cytometry, systemic rhNELL-1, Wnt/β-catenin inhibition, nonhuman primate spinal fusion\",\n      \"pmids\": [\"28614787\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional mechanism of Sca-1 induction unknown\", \"Receptor mediating progenitor effect not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established the chondrocyte-autonomous role of NELL1 in endochondral ossification—conditional deletion in cartilage impairs skeletogenesis via the Ihh–PTHrP feedback loop, with rescue blocked by Ihh inhibitors; NELL1 also signals through MAPK/ERK on osteogenic surfaces.\",\n      \"evidence\": \"Col2α1-Cre conditional knockout with micro-CT/histomorphometry and Ihh/PTHrP immunostaining, Ihh inhibitor rescue; ERK inhibitor U0126 blockade on Ti surfaces; Nell-1-ΔE/ENO-1 Co-IP/MS\",\n      \"pmids\": [\"30352124\", \"30359975\", \"29388706\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NELL1 engages the Ihh pathway molecularly unresolved\", \"Function of the ΔE splice variant/ENO-1 axis in vivo unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended NELL1 to neural crest skeletogenesis, a candidate osteogenic receptor, autoimmune kidney disease, and tumor suppression—Wnt1-lineage deletion causes craniofacial defects via reduced β-catenin, Cntnap4 was named as an osteogenic receptor, NELL1 is a membranous nephropathy autoantigen, and it restrains lung cancer stem-like cells.\",\n      \"evidence\": \"Wnt1-Cre conditional knockout with lineage tracing and protein rescue; review citation of Cntnap4; glomerular mass spectrometry/IHC/serology; NELL1 overexpression in lung cancer stem-like cells with pathway markers\",\n      \"pmids\": [\"31582804\", \"31610747\", \"31901340\", \"30628703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cntnap4 receptor claim is review-level, lacking primary detail (Low confidence)\", \"Lung cancer c-MET-Notch link lacks inhibitor/rescue validation (Low confidence)\", \"Mechanism converting NELL1 from skeletal factor to glomerular autoantigen unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealed a context-dependent oncogenic role—in osteosarcoma NELL1 sustains invasion and FAK signaling by shaping the matricellular environment, with ECM rescue restoring the phenotype.\",\n      \"evidence\": \"Genetic deletion in human OS lines, xenograft and p53/Rb-driven sarcoma conditional knockout, transcriptomics/phosphoproteomics, matricellular ECM rescue\",\n      \"pmids\": [\"35700263\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor mediating OS FAK signaling not specified\", \"Reconciliation of tumor-suppressive versus pro-invasive roles across cancers unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified an immunomodulatory function—NELL1 drives macrophage M1-to-M2 polarization through JNK/MAPK signaling, linking it to resolution of inflammation in bone-associated tissue.\",\n      \"evidence\": \"LPS-stimulated RAW 264.7 macrophages with JNK inhibitor SP600125 blockade, flow cytometry, plus rat periodontitis model\",\n      \"pmids\": [\"38908089\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor on macrophages not identified\", \"Single cell-line context for the polarization mechanism\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The unifying receptor logic remains open: how NELL1 reconciles integrin β1, integrin α3β1, and the proposed Cntnap4 into a coherent receptor system, and how the same molecule acts as osteoinductive factor, lineage gatekeeper, autoantigen, and context-dependent tumor modulator.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of receptor-bound NELL1\", \"No single study reconciles divergent receptor identifications\", \"Mechanism of autoantigen exposure in membranous nephropathy uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [2, 6, 11, 17]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 16]},\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [9, 14, 15]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [9, 14, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 17, 30]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 11, 17, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 4, 21, 22]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [4, 27]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 10]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [28, 30]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ITGB1\", \"ITGA3\", \"RUNX2\", \"SP7\", \"CNTNAP4\", \"APR3\", \"ENO1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}